Primary Care Clinics in Richmond, IN Accepting Medicare
42 Primary Care Clinics found. Showing 41 - 42
 Drs. Bode & Hartman Pc Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1471 Chester Blvd Ste A, Richmond, IN 47374 Phone: 765-935-4088 Fax: 765-966-2596 |
Reid Health Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1100 Reid Pkwy, Richmond, IN 47374 Phone: 765-983-3300 |
News Archive
Halozyme Therapeutics to advance core proprietary programs through key clinical inflection points
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced a focusing of its resources on advancing its core proprietary programs through key clinical inflection points in 2011 and 2012, and supporting strategic alliances with Roche and Baxter such as validation of Halozyme's commercial scale manufacturing process to produce kilogram quantities of enzyme.
Endovenous laser ablation is a safe and highly effective treatment for a common cause of varicose veins
Endovenous laser ablation is a safe and highly effective treatment for a common but under-recognized cause of varicose veins - reflux in a variety of veins collectively referred to as non-great saphenous veins - according to results of a study presented today at the 30th Annual Scientific Meeting of the Society of Interventional Radiology.
RBM and Covance sign biomarker alliance and services agreement
Rules-Based Medicine, Inc. (RBM) today announced it has entered into a biomarker alliance and services agreement with Covance Inc. that will provide biotechnology and pharmaceutical companies with a powerful combination of biomarker technologies and services for use in drug development. Under terms of the agreement, Covance will use RBM as its exclusive third-party provider of multiplexed protein biomarker testing services, and RBM shall use Covance as its exclusive referral source for laboratory testing services.
Final health care reform legislation requires comprehensive coverage of smoking cessation treatment
As Congress negotiates a final health care reform bill, lawmakers should seize this unprecedented opportunity to invest in proven measures that prevent costly diseases from occurring in the first place, which will improve health and reduce health care costs. These include measures to prevent and reduce tobacco use, which remains the leading cause of preventable death in the United States, killing more than 400,000 people and costing the nation $96 billion in health care expenditures annually.
Dezima starts DEZ-001 Phase 2b study in patients with mild dyslipidemia
Dezima Pharma, the biotechnology company developing innovative drugs in the field of dyslipidemia, announced today the initiation of a double blind, placebo controlled, Phase 2b dose ranging study of DEZ-001 (previously TA-8995), alone and in combination with statins, in order to study the effects on a wide range of lipids and other biomarkers of cardiovascular disease in patients with mild dyslipidemia.
› Verified 3 days ago